MCM
BSX icon

Marsico Capital Management’s Boston Scientific BSX Stock Holding History

Marsico Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,131,363
Closed -$33M – 95
2017
Q3 		$33M Sell
1,131,363
-7,716
-0.7% -$213K 1.32% 22
2017
Q2 		$31.6M Sell
1,139,079
-271
-0% -$7.19K 1.32% 21
2017
Q1 		$28.3M Buy
+1,139,350
New +$27.7M 1.23% 26

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Marsico Capital Management's BSX Position: Q4 2017 in Review

Marsico Capital Management sold out of Boston Scientific (BSX) in Q4 2017, closing a stake of 1,131,363 shares — an estimated $33M sold.

Marsico Capital Management first reported a position in BSX in Q1 2017 and held it in 3 quarters. The position peaked at $33M in Q3 2017. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • Marsico Capital Management reported no remaining Boston Scientific position as of Q4 2017 after selling out during the quarter.
  • Marsico Capital Management sold 1,131,363 Boston Scientific shares in Q4 2017, an estimated $33M.
  • Marsico Capital Management first reported a position in Boston Scientific in Q1 2017 and held it in 3 quarters.
  • Marsico Capital Management's Boston Scientific position peaked at $33M in Q3 2017.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on Marsico Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.